Cargando…

Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial

OBJECTIVE: To investigate the effects of mesotherapy in patients with mild to moderate knee osteoarthritis (KOA). METHODS: The study included 43 patients (56 knees) who were randomly assigned to either the mesotherapy group (MG, n=28) or the saline group (SG, n=28) and received a total of 4 weekly m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseveendorj, Narangerel, Sindel, Dilsad, Arman, Sina, Sen, Ekin Ilke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976173/
https://www.ncbi.nlm.nih.gov/pubmed/36856100
_version_ 1784899011633741824
author Tseveendorj, Narangerel
Sindel, Dilsad
Arman, Sina
Sen, Ekin Ilke
author_facet Tseveendorj, Narangerel
Sindel, Dilsad
Arman, Sina
Sen, Ekin Ilke
author_sort Tseveendorj, Narangerel
collection PubMed
description OBJECTIVE: To investigate the effects of mesotherapy in patients with mild to moderate knee osteoarthritis (KOA). METHODS: The study included 43 patients (56 knees) who were randomly assigned to either the mesotherapy group (MG, n=28) or the saline group (SG, n=28) and received a total of 4 weekly mesotherapy (MG) or saline injections (SG). Pain, functional status and quality of life were evaluated by a Visual Analogue Scale (VAS), the Western Ontario Universities Osteoarthritis Index (WOMAC) and the Short Form-36 (SF-36) subscales at baseline and at 8 and 16 weeks of follow-up. RESULTS: A total of 39 patients (52 knees) completed the study. Eight weeks after treatment, a significant improvement was found in VAS pain scores, WOMAC scores and physical component scores (PCS) of the SF-36 in both groups compared to baseline (p<0.05). The VAS activity pain score, WOMAC-pain, WOMAC-physical function and WOMAC-total scores were found to have decreased significantly in the MG compared to the SG (p<0.001) at both 8 weeks and 16 weeks. The PCS scores significantly improved in the MG compared to the SG at 8- and 16-week follow-ups (p<0.001 and p<0.001, respectively). CONCLUSIONS: Mesotherapy is a well-tolerated, safe and effective alternative treatment option in patients with mild and moderate KOA.
format Online
Article
Text
id pubmed-9976173
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Society of Musculoskeletal and Neuronal Interactions
record_format MEDLINE/PubMed
spelling pubmed-99761732023-03-02 Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial Tseveendorj, Narangerel Sindel, Dilsad Arman, Sina Sen, Ekin Ilke J Musculoskelet Neuronal Interact Original Article OBJECTIVE: To investigate the effects of mesotherapy in patients with mild to moderate knee osteoarthritis (KOA). METHODS: The study included 43 patients (56 knees) who were randomly assigned to either the mesotherapy group (MG, n=28) or the saline group (SG, n=28) and received a total of 4 weekly mesotherapy (MG) or saline injections (SG). Pain, functional status and quality of life were evaluated by a Visual Analogue Scale (VAS), the Western Ontario Universities Osteoarthritis Index (WOMAC) and the Short Form-36 (SF-36) subscales at baseline and at 8 and 16 weeks of follow-up. RESULTS: A total of 39 patients (52 knees) completed the study. Eight weeks after treatment, a significant improvement was found in VAS pain scores, WOMAC scores and physical component scores (PCS) of the SF-36 in both groups compared to baseline (p<0.05). The VAS activity pain score, WOMAC-pain, WOMAC-physical function and WOMAC-total scores were found to have decreased significantly in the MG compared to the SG (p<0.001) at both 8 weeks and 16 weeks. The PCS scores significantly improved in the MG compared to the SG at 8- and 16-week follow-ups (p<0.001 and p<0.001, respectively). CONCLUSIONS: Mesotherapy is a well-tolerated, safe and effective alternative treatment option in patients with mild and moderate KOA. International Society of Musculoskeletal and Neuronal Interactions 2023 /pmc/articles/PMC9976173/ /pubmed/36856100 Text en Copyright: © Journal of Musculoskeletal and Neuronal Interactions https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tseveendorj, Narangerel
Sindel, Dilsad
Arman, Sina
Sen, Ekin Ilke
Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial
title Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial
title_full Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial
title_fullStr Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial
title_full_unstemmed Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial
title_short Efficacy of Mesotherapy for Pain, Function and Quality of Life in Patients with Mild and Moderate Knee Osteoarthritis: A Randomized Controlled Trial
title_sort efficacy of mesotherapy for pain, function and quality of life in patients with mild and moderate knee osteoarthritis: a randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976173/
https://www.ncbi.nlm.nih.gov/pubmed/36856100
work_keys_str_mv AT tseveendorjnarangerel efficacyofmesotherapyforpainfunctionandqualityoflifeinpatientswithmildandmoderatekneeosteoarthritisarandomizedcontrolledtrial
AT sindeldilsad efficacyofmesotherapyforpainfunctionandqualityoflifeinpatientswithmildandmoderatekneeosteoarthritisarandomizedcontrolledtrial
AT armansina efficacyofmesotherapyforpainfunctionandqualityoflifeinpatientswithmildandmoderatekneeosteoarthritisarandomizedcontrolledtrial
AT senekinilke efficacyofmesotherapyforpainfunctionandqualityoflifeinpatientswithmildandmoderatekneeosteoarthritisarandomizedcontrolledtrial